Current Report Filing (8-k)
June 29 2018 - 5:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 29, 2018
ReWalk
Robotics Ltd.
(Exact name of registrant as specified in its
charter)
Israel
|
|
001-36612
|
|
Not applicable
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
3 Hatnufa St., Floor 6, Yokneam Ilit, Israel
|
|
2069203
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
+972.4.959.0123
(Former name or former address, if changed since
last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (
see
General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 8.01 Other Events.
As previously disclosed
on a Current Report on Form 8-K filed on May 17, 2016 with the Securities and Exchange Commission (the “SEC”), on May
16, 2016, ReWalk Robotics Ltd. (“we,” “us” or the “Company”) entered into a Research Collaboration
Agreement (the “Collaboration Agreement”) and an Exclusive License Agreement (the “License Agreement”)
with the President and Fellows of Harvard College (“Harvard”). Under the Collaboration Agreement, the Company and Harvard
agree to collaborate on research regarding the development of lightweight “soft suit” exoskeleton system technologies
for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other
medical applications. Under the License Agreement, the Company is granted an exclusive, worldwide royalty-bearing license under
certain patents of Harvard relating to lightweight “soft suit” exoskeleton system technologies for lower limb disabilities,
a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under
the parties’ joint research collaboration.
On May 1, 2017,
Harvard and the Company entered into Amendment No. 1 to the Collaboration Agreement (the “Collaboration Agreement Amendment”).
On April 1, 2018, Harvard and the Company entered into Amendment No. 1 to the License Agreement and Amendment No. 2 to the Collaboration
Agreement (the “Joint Amendment”). This Current Report on Form 8-K is being filed with the SEC for the sole purpose
of filing the Collaboration Agreement Amendment and Joint Amendment as Exhibits 10.1 and 10.2, respectively.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
* Confidential treatment has been requested
for portions of this document. The omitted portions of this document have been filed with the SEC as required by Rule 24b-2 under
the Securities Exchange Act of 1934, as amended.
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ReWalk Robotics Ltd.
|
|
|
|
By:
|
/s/ Ori Gon
|
|
Name:
|
Ori Gon
|
|
Title:
|
Chief Financial Officer
|
Dated: June 29, 2018
3
EXHIBIT INDEX
* Confidential treatment has been requested
for portions of this document. The omitted portions of this document have been filed with the Commission as required by Rule 24b-2
under the Securities Exchange Act of 1934, as amended.
ReWalk Robotics (NASDAQ:RWLK)
Historical Stock Chart
From Mar 2024 to Apr 2024
ReWalk Robotics (NASDAQ:RWLK)
Historical Stock Chart
From Apr 2023 to Apr 2024